--- title: "Consun Pharmaceutical Group (1681) stock and investor profile" url: "https://aibio.space/companies/consun-pharmaceutical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Consun Pharmaceutical Group Ltd. (HKEX: 1681), China. The directory classifies it as Pharmaceuticals: Major." --- 1681 Consun Pharmaceutical Group Ltd. HKEX · China # Consun Pharmaceutical Group (1681) news Consun Pharmaceutical Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1681, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Consun Pharmaceutical Group news We have not published a story on Consun Pharmaceutical Group yet. When there is news, it will appear here. ## Consun Pharmaceutical Group at a glance - **Ticker**: 1681 - **Listing**: HKEX - **Country**: China ### Related companies - [China National Accord Medicines Corporation](https://aibio.space/companies/china-national-accord-medicines/) SZSE: 000028 - [Shandong Wohua Pharmaceutical Co.](https://aibio.space/companies/shandong-wohua-pharmaceutical/) SZSE: 002107 - [Shandong Boan Biotechnology Company., Limited.](https://aibio.space/companies/shandong-boan-biotechnology/) HKEX: 6955 - [RemeGen Co.](https://aibio.space/companies/remegen/) SSE: 688331 - [Wuhan YZY Biopharma Co.](https://aibio.space/companies/wuhan-yzy-biopharma/) HKEX: 2496 - [Hunan Fangsheng Pharmaceutical Co.](https://aibio.space/companies/hunan-fangsheng-pharmaceutical/) SSE: 603998 - [Hunan Er-Kang Pharmaceutical Co.](https://aibio.space/companies/hunan-er-kang-pharmaceutical/) SZSE: 300267 - [Modern Chinese Medicine Group Co.](https://aibio.space/companies/modern-chinese-medicine/) HKEX: 1643 ### Also on HKEX - [3SBio](https://aibio.space/companies/3sbio/) 1530 - [China Regenerative Medicine International](https://aibio.space/companies/china-regenerative-medicine-international/) 8158 - [New Ray Medicine International Holding](https://aibio.space/companies/new-ray-medicine-international/) 6108 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) 1779 - [CStone Pharmaceuticals](https://aibio.space/companies/cstone-pharmaceuticals/) 2616 - [CK Life Sciences International (Holdings)](https://aibio.space/companies/ck-life-sciences-international/) 775 ## Questions about Consun Pharmaceutical Group What is the ticker symbol of Consun Pharmaceutical Group? Consun Pharmaceutical Group Ltd. trades under the ticker 1681 on HKEX. Where is Consun Pharmaceutical Group listed? Consun Pharmaceutical Group Ltd. is listed on HKEX. Our directory also records these other listings: LS:A1XAEC; LSX:A1XAEC. Which country or territory is Consun Pharmaceutical Group listed under? Our directory records Consun Pharmaceutical Group Ltd. under China. What does Consun Pharmaceutical Group do? Our directory classifies Consun Pharmaceutical Group Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Consun Pharmaceutical Group? The ISIN recorded for Consun Pharmaceutical Group Ltd. is KYG2524A1031. Does aibio.space cover Consun Pharmaceutical Group? aibio.space lists Consun Pharmaceutical Group Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Consun Pharmaceutical Group? Companies in our directory listed in the same country and business area as Consun Pharmaceutical Group: China National Accord Medicines Corporation, Shandong Wohua Pharmaceutical Co., Shandong Boan Biotechnology Company., Limited., RemeGen Co., Wuhan YZY Biopharma Co., Hunan Fangsheng Pharmaceutical Co.. ## Investor discussion: Consun Pharmaceutical Group Members talk about Consun Pharmaceutical Group (1681). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Consun Pharmaceutical Group, newest first. Each line links the filing it comes from. 1. 2025-08-04 Mergers Transaction under the Listing Rules: DISCLOSEABLE TRANSACTIONS SUBSCRIPTIONS FOR WEALTH MANAGEMENT PRODUCTS. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0804/2025080402192.pdf) ## Press releases Headlines of Consun Pharmaceutical Group's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-23 HKEXnews [Notification Letter to Non-Registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092400025.pdf) 2. 2026-09-23 HKEXnews [Notification Letter to Registered Shareholders and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092400021.pdf) 3. 2026-08-26 HKEXnews [Interim Dividend for the six months ended 30 June 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600229.pdf) 4. 2026-08-26 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0826/2026082600201.pdf) 5. 2026-06-08 HKEXnews [VOLUNTARY ANNOUNCEMENT ACQUISITION OF 30% EQUITY INTEREST IN SHANGHAI HUAMAO PHARMACEUTICAL CO., LTD.](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0608/2026060800324.pdf) 6. 2026-05-27 HKEXnews [VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE PROGRAM UNDER THE REPURCHASE MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0527/2026052701348.pdf) 7. 2026-05-26 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, 26 MAY 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600578.pdf) 8. 2026-04-27 HKEXnews [Notification Letter to Shareholders - Annual General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800127.pdf) 9. 2026-04-27 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042800109.pdf) 10. 2026-03-26 HKEXnews [Final Dividend for the year ended 31 December 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032600317.pdf) 11. 2026-03-26 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0326/2026032600303.pdf) 12. 2025-12-23 HKEXnews [Terms of Reference of the Environmental, Social and Governance Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1223/2025122301224.pdf) 13. 2025-12-23 HKEXnews [THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1223/2025122301198.pdf) 14. 2025-12-23 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, 23 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1223/2025122301190.pdf) 15. 2025-12-08 HKEXnews [2025 Share Award Scheme](https://www1.hkexnews.hk/listedco/listconews/sehk/dod/en.html) 16. 2025-12-08 HKEXnews [Notification Letter to Shareholders - Extraordinary General Meeting](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1208/2025120800073.pdf) 17. 2025-12-08 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1208/2025120800061.pdf) 18. 2025-12-08 HKEXnews [(1) PROPOSED ADOPTION OF THE SHARE AWARD SCHEME, (2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (3) NOTICE OF EGM](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1208/2025120800057.pdf) 19. 2025-12-02 HKEXnews [BOOK CLOSURE PERIOD AND RECORD DATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1202/2025120201456.pdf) 20. 2025-11-06 HKEXnews [PROPOSED ADOPTION OF SHARE AWARD SCHEME](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1106/2025110601784.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:1681 on TradingView](https://www.tradingview.com/symbols/HKEX-1681/). ## Listing details Consun Pharmaceutical Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 1681, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Consun Pharmaceutical Group Ltd. - **Ticker**: 1681 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Major - **ISIN**: KYG2524A1031 - **Other listed symbols**: LS:A1XAEC; LSX:A1XAEC - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-1681/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/consun-pharmaceutical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Consun Pharmaceutical Group (1681) stock and investor profile", 2026-10-31, https://aibio.space/companies/consun-pharmaceutical/